» Articles » PMID: 29930717

OCT4B Regulates P53 and P16 Pathway Genes to Prevent Apoptosis of Breast Cancer Cells

Overview
Journal Oncol Lett
Specialty Oncology
Date 2018 Jun 23
PMID 29930717
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Octamer-binding transcription factor 4 (OCT4) is a transcription factor with a well-defined role in stem cell pluripotency. Two OCT4 isoforms, OCT4A and OCT4B, tend to be downregulated as normal cells differentiate. However, OCT4, particularly OCT4B, may become reactivated in cancer cells. Despite this observation, the exact function of OCT4B re-expression in cancer is unclear. In the present study, the role of OCT4 in breast cancer cells was determined. In particular, the ability of OCT4 to regulate key genes involved in cellular proliferation and apoptosis, two pathways that are frequently deregulated in cancer, was examined. The cyclin-dependent kinase inhibitor 2A locus encodes p16INK4a and p14ARF, two important cell cycle inhibitors. The tumor suppressor p53 also has well characterized roles in suppressing proliferation and promoting apoptosis. The present study demonstrated, via overexpression and genetic knockdown techniques, that OCT4B regulates the expression of several of these genes and ultimately regulates the rate of apoptosis of MCF-7 breast cancer cells. It was also observed that, while OCT4B and OCT4A regulate one another, it is OCT4B that serves a more prominent role in regulating the transcription of downstream genes. Taken together, the present results suggest that OCT4B is re-expressed in a number of breast cancer cell lines, where it affects both the transcription of cell cycle genes and the rate of apoptosis. These properties of OCT4B may depend on, at least in part, the co-function of OCT4A.

Citing Articles

Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance.

Niharika , Garg M Expert Rev Mol Med. 2024; 26:e23.

PMID: 39375840 PMC: 11488345. DOI: 10.1017/erm.2024.23.


Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p.

Zhou W, Yang Y, Wang W, Yang C, Cao Z, Lin X Cell Cycle. 2024; 23(6):645-661.

PMID: 38842275 PMC: 11229759. DOI: 10.1080/15384101.2024.2353554.


Revisiting Epithelial Carcinogenesis.

Mendez-Lopez L Int J Mol Sci. 2022; 23(13).

PMID: 35806442 PMC: 9267463. DOI: 10.3390/ijms23137437.


Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1.

Wang W, Wei C, Cui X, Li Y, Gu Y, Gu B Front Neurol. 2021; 12:704639.

PMID: 34566848 PMC: 8455870. DOI: 10.3389/fneur.2021.704639.


Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.

Nathansen J, Lukiyanchuk V, Hein L, Stolte M, Borgmann K, Lock S Oncogene. 2021; 40(24):4214-4228.

PMID: 34079088 PMC: 8211562. DOI: 10.1038/s41388-021-01842-1.


References
1.
Cao Y, Siegel D, Knochel W . Xenopus POU factors of subclass V inhibit activin/nodal signaling during gastrulation. Mech Dev. 2006; 123(8):614-25. DOI: 10.1016/j.mod.2006.06.004. View

2.
Sherr C . Divorcing ARF and p53: an unsettled case. Nat Rev Cancer. 2006; 6(9):663-73. DOI: 10.1038/nrc1954. View

3.
Gao Y, Wei J, Han J, Wang X, Su G, Zhao Y . The novel function of OCT4B isoform-265 in genotoxic stress. Stem Cells. 2012; 30(4):665-72. DOI: 10.1002/stem.1034. View

4.
Wang Y, Meng L, Hu H, Zhang Y, Zhao C, Li Q . Oct-4B isoform is differentially expressed in breast cancer cells: hypermethylation of regulatory elements of Oct-4A suggests an alternative promoter and transcriptional start site for Oct-4B transcription. Biosci Rep. 2010; 31(2):109-15. DOI: 10.1042/BSR20100033. View

5.
Kim W, Sharpless N . The regulation of INK4/ARF in cancer and aging. Cell. 2006; 127(2):265-75. DOI: 10.1016/j.cell.2006.10.003. View